LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026)
LivaNova (LIVN) posted Total Non-Current Liabilities of $1.3 billion for Q1 2026, down 8.31% sequentially from $1.4 billion in Q4 2025, and down 15.33% YoY from $1.5 billion in Q1 2025.
LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has reported Total Non-Current Liabilities for 12 years, with the latest figure at $1.3 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 15.33% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 15.33% YoY) and the FY2025 annual result came in at $1.4 billion, up 19.48% from the prior year.
- Total Non-Current Liabilities fell to $1.3 billion in Q1 2026 per LIVN's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $1.5 billion in Q1 2025 and troughed at $1.0 billion in Q4 2022.
- A 5-year average of $1.2 billion and a median of $1.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities retreated 20.01% in 2022, then jumped 30.36% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $1.0 billion in 2022, then rose by 6.9% to $1.1 billion in 2023, then increased by 6.59% to $1.1 billion in 2024, then increased by 19.48% to $1.4 billion in 2025, then decreased by 8.31% to $1.3 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.3 billion, $1.4 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.82 Bn | 124.35 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.38 Bn | 72.84 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.44 Bn | 32.50 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.80 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 3.44 Bn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.25 Bn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | 1.34 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | 1.07 Bn |
| Sep 30, 2023 | 1.06 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 1.00 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 1.01 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 819.48 Mn |
| Sep 30, 2021 | 786.83 Mn |